AI Buyer Insights:

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Michelin, an e2open customer evaluated Oracle Transportation Management

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Michelin, an e2open customer evaluated Oracle Transportation Management

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

List of Veeva CTMS Customers

Apply Filters For Customers

Logo Customer Industry Empl. Revenue Country Vendor Application Category When SI Insight
Atlantic Research Group Professional Services 10 $1M United States Veeva Systems Veeva CTMS Clinical Trial Management 2020 n/a
In 2020, Atlantic Research Group adopted Veeva CTMS as part of a Clinical Trial Management deployment to centralize clinical operations within the United States. The program deployed Veeva Vault CTMS alongside Veeva eTMF to unify study documentation, improve TMF quality, and increase cross‑study visibility for the small CRO's clinical teams. The implementation focused on core Clinical Trial Management capabilities, including study setup workflows, trial master file governance, and automated document handling. Veeva Vault CTMS was configured to orchestrate study milestones and to drive automatic trip report filing into the Veeva eTMF, reducing manual handoffs and accelerating administrative setup tasks. Operational coverage centered on the clinical operations function in the United States, with integrations established between the CTMS and the eTMF to maintain a single source of truth for regulatory documentation. Governance updates emphasized TMF quality controls and inspection readiness, and outcomes noted by the customer included reduced study setup time, automated trip report filing into the TMF, and improved inspection readiness.
Linical Europe Life Sciences 1000 $250M Germany Veeva Systems Veeva CTMS Clinical Trial Management 2021 n/a
In 2021, Linical Europe implemented Veeva CTMS for Clinical Trial Management. The deployment established Veeva CTMS as the central system of record for clinical study tracking and operational orchestration within its clinical teams. Configuration and functional scope emphasized Clinical Trial Management capabilities such as study planning, monitoring visit management, protocol milestone tracking, and linking of trial documentation to study records. Veeva CTMS was configured to provide monitoring scheduling, visit reporting, and visibility into document and TMF status consistent with industry CTMS workflows. The implementation model references a paired Veeva Vault eTMF integration as executed by Linical Americas, where Veeva Vault CTMS was implemented together with Vault eTMF to unify study planning, site monitoring, and TMF workflows across CRO operations. That referenced linkage demonstrates an integrated content and operational architecture, where CTMS record objects are connected to eTMF artifacts to support TMF delivery processes. Governance centered on centralized clinical operations oversight, standardized monitoring and TMF workflows, and phased rollout across study teams to align operational processes. Linical Americas reported that its clinical operations rollout in the United States cut study setup time roughly in half and sped TMF delivery to sponsors by about 75 percent, providing a documented outcome associated with the combined CTMS and eTMF approach.
Penumbra, Inc. Life Sciences 3900 $847M United States Veeva Systems Veeva CTMS Clinical Trial Management 2017 n/a
In 2017, Penumbra, Inc. implemented Veeva CTMS to streamline clinical operations in the United States. The deployment targeted Clinical Trial Management and was publicly named by Veeva as an early adoption to simplify clinical trial management and to integrate CTMS with eTMF. The Veeva CTMS configuration focused on core CTMS capabilities common to the Clinical Trial Management category, including study planning and tracking, site and subject management, monitoring and visit tracking, and milestone and protocol status visibility. The implementation emphasized document linkage and cross‑reference workflows between trial records and the enterprise eTMF, and incorporated role based access and audit trail capabilities to support clinical oversight and compliance. Operational coverage was centered on clinical operations within the United States, with governance oriented around centralized study level visibility and standardized monitoring and study execution workflows. The stated objective and outcome was improved trial process efficiency and greater transparency across studies, aligning Penumbra, Inc. clinical operations with Veeva Systems CTMS capabilities.
Showing 1 to 3 of 3 entries

Buyer Intent: Companies Evaluating Veeva CTMS

ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating Veeva CTMS. Gain ongoing access to real-time prospects and uncover hidden opportunities.

Discover Software Buyers actively Evaluating Enterprise Applications

Logo Company Industry Employees Revenue Country Evaluated
No data found
FAQ - APPS RUN THE WORLD Veeva CTMS Coverage

Veeva CTMS is a Clinical Trial Management solution from Veeva Systems.

Companies worldwide use Veeva CTMS, from small firms to large enterprises across 21+ industries.

Organizations such as Penumbra, Inc., Linical Europe and Atlantic Research Group are recorded users of Veeva CTMS for Clinical Trial Management.

Companies using Veeva CTMS are most concentrated in Life Sciences and Professional Services, with adoption spanning over 21 industries.

Companies using Veeva CTMS are most concentrated in United States and Germany, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of Veeva CTMS across Americas, EMEA, and APAC.

Companies using Veeva CTMS range from small businesses with 0-100 employees - 33.33%, to mid-sized firms with 101-1,000 employees - 33.33%, large organizations with 1,001-10,000 employees - 33.33%, and global enterprises with 10,000+ employees - 0%.

Customers of Veeva CTMS include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.

Contact APPS RUN THE WORLD to access the full verified Veeva CTMS customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Clinical Trial Management.